“Viatris Octreotide Syringes Recall: Glass Particles Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34299-viatris-octreotide-syringes-recall-glass-particles-risk. Based on FDA recall #D-0058-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0058-2023%22&limit=1).
The FDA announced on October 7, 2022, that Viatris Inc. is recalling Octreotide Acetate Injection 500 mcg/mL syringes due to the presence of particulate matter. The recall involves 22,400 units distributed nationwide.
How to tell if you have it
Brand: Viatris
Product: Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes
The product complaint cited the presence of glass particles in a syringe. The FDA classified this as a Class I recall.
Context
GovInfoNow's records show Viatris, Inc. has 10 other recalls on record since April 28, 2022. Other recent recalls of similar products include Sun Pharmaceutical DOXOrubin Liposome Injection Recall (May 12, 2026), Cipla Lanreotide Injection Recall (January 2, 2026), and Mallinckrodt Acthar Gel 5mL Vial Recall (August 6, 2026).
How to tell if you have this one
Check for syringes labeled 'Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes'. They were made in Italy with NDC 67457-246-00 (syringe) and 67457-246-01 (carton).
Brand
Viatris
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Syringe Label
Look for the NDC numbers 67457-246-00 (syringe) and 67457-246-01 (carton) on the product.
Stop Using If Concerned
If you have the recalled syringes, stop using them immediately to avoid potential injury from glass particles.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0058-2023 (October 7, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0058-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.